← Back to Search

Telomere Education for Heart Attack Prevention

N/A
Waitlist Available
Led By J. Geoffrey Pickering, MD PhD
Research Sponsored by Western University, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Individuals with genetic mutations that affect telomere length
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if giving people personalized information about their cellular aging, including telomere length, will motivate them to follow heart health strategies and improve their exercise endurance.

Who is the study for?
This trial is for people who have had a heart attack and are now in a cardiac rehabilitation program. It's designed to see if learning about cellular aging can help them stick to heart health strategies.
What is being tested?
The study tests whether education on telomere length, an indicator of cellular aging, motivates participants to follow secondary prevention measures for heart health and improves their exercise capacity.
What are the potential side effects?
Since the intervention involves education only, there are no direct medical side effects expected from participating in this trial.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a genetic mutation that affects the length of my telomeres.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cardiopulmonary Exercise Test
Secondary study objectives
Activity assessment
Adherence to supervised exercise sessions

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Knowledge transfer groupExperimental Treatment1 Intervention
Participants receive standard care in cardiac rehabilitation program plus education regarding telomere length
Group II: ControlActive Control1 Intervention
Participants receive standard care in cardiac rehabilitation program

Find a Location

Who is running the clinical trial?

Western University, CanadaLead Sponsor
253 Previous Clinical Trials
58,372 Total Patients Enrolled
J. Geoffrey Pickering, MD PhDPrincipal InvestigatorWestern Faculty
~30 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top